Oligopeptides

Antiviral Agents
Activities of Atazanavir (BMS-232632) against a Large Panel of Human Immunodeficiency Virus Type 1 Clinical Isolates Resistant to One or More Approved Protease Inhibitors
Richard J. Colonno, Alexandra Thiry, Kay Limoli, Neil Parkin
Mechanisms of Action: Physiological Effects
Effect of Auristatin PHE on Microtubule Integrity and Nuclear Localization in Cryptococcus neoformans
Tanja Woyke, Robert W. Roberson, George R. Pettit, Günther Winkelmann, Robin K. Pettit
Antiviral Agents
Tripeptide Interference with Human Immunodeficiency Virus Type 1 Morphogenesis
Stefan Höglund, Jin Su, Sara Sandin Reneby, Ákos Végvári, Stellan Hjertén, Ida-Maria Sintorn, Hillary Foster, Yi-Pyng Wu, Ingela Nyström, Anders Vahlne
Experimental Therapeutics
Reducing Mortality in Salmonella enterica Serovar Typhimurium-Infected Mice with a Tripeptidic Serum Fraction
Todd A. Parker, Kenneth O. Willeford, Suzanne Parker, Karyl Buddington
Antiviral Agents
Oxidative Modifications of Kynostatin-272, a Potent Human Immunodeficiency Virus Type 1 Protease Inhibitor: Potential Mechanism for Altered Activity in Monocytes/Macrophages
David A. Davis, Elizabeth Read-Connole, Kara Pearson, Henry M. Fales, Fonda M. Newcomb, Jackob Moskovitz, Robert Yarchoan
Susceptibility
In Vitro Activities and Postantifungal Effects of the Potent Dolastatin 10 Derivative Auristatin PHE
Tanja Woyke, George R. Pettit, Günther Winkelmann, Robin K. Pettit
Antiviral Agents
In Vitro Resistance Profile of the Human Immunodeficiency Virus Type 1 Protease Inhibitor BMS-232632
Yi-Fei Gong, Brett S. Robinson, Ronald E. Rose, Carol Deminie, Timothy P. Spicer, David Stock, Richard J. Colonno, Pin-fang Lin
Antiviral Agents
BMS-232632, a Highly Potent Human Immunodeficiency Virus Protease Inhibitor That Can Be Used in Combination with Other Available Antiretroviral Agents
Brett S. Robinson, Keith A. Riccardi, Yi-fei Gong, Qi Guo, David A. Stock, Wade S. Blair, Brian J. Terry, Carol A. Deminie, Fred Djang, Richard J. Colonno, Pin-fang Lin
Susceptibility
In Vitro Antifungal Activity and Cytotoxicity of a Novel Membrane-Active Peptide
Sung Yu Hong, Jong Eun Oh, Keun Hyeung Lee
Pharmacology
Metabolic Characterization of a Tripeptide Human Immunodeficiency Virus Type 1 Protease Inhibitor, KNI-272, in Rat Liver Microsomes
Akiko Kiriyama, Tomoyuki Nishiura, Hirokazu Yamaji, Kanji Takada

Pages